Dr. Jonathon Cohen, MD
Claim this profileEmory University Hospital/Winship Cancer Institute
Studies Mantle Cell Lymphoma
Studies Diffuse Large B-Cell Lymphoma
8 reported clinical trials
13 drugs studied
Area of expertise
1Mantle Cell Lymphoma
Stage I
t(11;14)
t(11;14) positive
2Diffuse Large B-Cell Lymphoma
MYC positive
BCL2 positive
BCL6 positive
Affiliated Hospitals
Clinical Trials Jonathon Cohen, MD is currently running
Long-Term Follow-Up
for CAR-T Therapy Safety
Per Health Authorities guidelines for gene therapy medicinal products that utilize integrating vectors (e.g. lentiviral vectors), long term safety and efficacy follow up of treated patients is required. The purpose of this study is to monitor all patients exposed to CAR-T therapied for 15 years following their last CAR-T (e.g. CTL019) infusion to assess the risk of delayed adverse events (AEs), monitor for replication competent lentivirus (RCL) and assess long-term efficacy, including vector persistence.
Recruiting2 awards Phase 32 criteria
Zanubrutinib
for Mantle Cell Lymphoma
This phase III trial tests whether continuous or intermittent zanubrutinib after achieving a complete remission (CR) with rituximab works in older adult patients with mantle cell lymphoma (MCL) who have not received treatment in the past (previously untreated). Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Zanubrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. When zanubrutinib is used in MCL, the current standard of care is to continue administering the drug indefinitely until disease progression. This continuous treatment comes with clinical as well as financial toxicity, which could be especially detrimental in older patients. For patients who achieve a CR after initial zanubrutinib plus rituximab therapy, it may be safe and equally effective to stop treatment and restart zanubrutinib upon disease progression rather than continuing indefinitely in previously untreated older adult patients with MCL.
Recruiting2 awards Phase 310 criteria
More about Jonathon Cohen, MD
Clinical Trial Related10 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Jonathon Cohen, MD has experience with
- Ibrutinib
- CAR-T
- CTL019
- Cyclophosphamide
- Oral Azacitidine
- Rituximab
Breakdown of trials Jonathon Cohen, MD has run
Mantle Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Lymphoma
Non-Hodgkin's Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathon Cohen, MD specialize in?
Jonathon Cohen, MD focuses on Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma. In particular, much of their work with Mantle Cell Lymphoma has involved Stage I patients, or patients who are t(11;14).
Is Jonathon Cohen, MD currently recruiting for clinical trials?
Yes, Jonathon Cohen, MD is currently recruiting for 3 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Jonathon Cohen, MD has studied deeply?
Yes, Jonathon Cohen, MD has studied treatments such as Ibrutinib, CAR-T, CTL019.
What is the best way to schedule an appointment with Jonathon Cohen, MD?
Apply for one of the trials that Jonathon Cohen, MD is conducting.
What is the office address of Jonathon Cohen, MD?
The office of Jonathon Cohen, MD is located at: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia 30322 United States. This is the address for their practice at the Emory University Hospital/Winship Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.